BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 3, 1997
View Archived Issues
Natural immunosuppressive agent disclosed by Kyowa Hakko
Read More
Kyowa Hakko discovers antitumor compounds in Streptomyces culture
Read More
Antimicrobial/cytotoxic compound isolated from fungal strain by Boehringer Mannheim
Read More
Novel antifibrillatory agent: DP-16
Read More
TAK-225 stimulates airways mucociliary transport
Read More
Rebamipide for diabetic nephropathy
Read More
Effects of thrombin inhibitor with or without gpIIb/IIIa antagonist during coronary thrombolysis
Read More
Orally active H3 receptor agonist prodrug with antiinflammatory/antinicoceptive properties
Read More
Roche's T-type calcium channel blocker receives European approval
Read More
Company profile: NexMed
Read More
FDA approves Mirapex for the treatment of Parkinson's disease
Read More
Company profile: NeoPharm
Read More
Company profile: GlycoDesign
Read More
Promising preliminary phase II results obtained for Protovir in bone marrow transplant patients
Read More
Hyal's treatment for sun spots approved in the U.K.
Read More
Encouraging phase I trial results reported with MDX-33
Read More
Shield Diagnostics acquires Murex subsidiary
Read More
ACT licenses rights to patents related to dendritic cell therapy
Read More
New cardiovascular gene therapy company launched in the U.K.
Read More
Emdogain approved in South Africa
Read More
Sugen files IND for angiogenesis inhibitor
Read More
BMS to develop products using CIMA's OraSolv oral delivery technology
Read More
